v3.26.1
Segment Information - Schedule of Segment Data (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Significant expenses:    
Sales and marketing $ 5,615 $ 4,565
Research and development 1,413 793
Share-based compensation 1,313 2,088
Depreciation and amortization 425 496
Restructuring costs 484 555
Total operating expenses 20,986 17,806
Reportable Segment    
Segment Reporting Information [Line Items]    
Adjusted EBITDA 5,079 2,289
Significant expenses:    
Sales and marketing 5,615 4,565
Research and development 1,413 793
General and administrative, excluding transaction costs 10,777 9,269
Share-based compensation 1,313 2,088
Depreciation and amortization 425 496
Total significant expenses 19,543 17,211
Restructuring costs 484 555
Transaction costs 959 40
Total operating expenses $ 20,986 $ 17,806